4.8 Article

Inhibition of yeast telomerase action by the telomeric ssDNA-binding protein, Cdc13p

Journal

NUCLEIC ACIDS RESEARCH
Volume 37, Issue 2, Pages 354-367

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkn830

Keywords

-

Funding

  1. National Institutes of Health [GM59414, GM28039, K99 GM80400, T32 GM65103, R00 GM80400]

Ask authors/readers for more resources

Appropriate control of the chromosome end-replicating enzyme telomerase is crucial for maintaining telomere length and genomic stability. The essential telomeric DNA-binding protein Cdc13p both positively and negatively regulates telomere length in budding yeast. Here we test the effect of purified Cdc13p on telomerase action in vitro. We show that the full-length protein and its DNA-binding domain (DBD) inhibit primer extension by telomerase. This inhibition occurs by competitive blocking of telomerase access to DNA. To further understand the requirements for productive telomerase 3-end access when Cdc13p or the DBD is bound to a telomerase substrate, we constrained protein binding at various distances from the 3-end on two sets of increasingly longer oligonucleotides. We find that Cdc13p inhibits the action of telomerase through three distinct biochemical modes, including inhibiting telomerase even when a significant tail is available, representing a novel action at a distance inhibitory activity. Thus, while yeast Cdc13p exhibits the same general activity as human POT1, providing an off switch for telomerase when bound near the 3-end, there are significant mechanistic differences in the ways telomere end-binding proteins inhibit telomerase action.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available